- Home
- ORIC vs VINP Comparison
ORIC vs VINP Comparison
Compare ORIC & VINP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORIC
- VINP
- Stock Information
- Founded
- ORIC 2014
- VINP 2009
- Country
- ORIC United States
- VINP Brazil
- Employees
- ORIC N/A
- VINP N/A
- Industry
- ORIC Biotechnology: Pharmaceutical Preparations
- VINP Investment Managers
- Sector
- ORIC Health Care
- VINP Finance
- Exchange
- ORIC Nasdaq
- VINP Nasdaq
- Market Cap
- ORIC 735.3M
- VINP 641.7M
- IPO Year
- ORIC 2020
- VINP 2021
- Fundamental
- Price
- ORIC $11.08
- VINP $10.35
- Analyst Decision
- ORIC Strong Buy
- VINP Strong Buy
- Analyst Count
- ORIC 9
- VINP 2
- Target Price
- ORIC $18.75
- VINP $13.50
- AVG Volume (30 Days)
- ORIC 825.1K
- VINP 62.7K
- Earning Date
- ORIC 03-10-2025
- VINP 02-26-2025
- Dividend Yield
- ORIC N/A
- VINP 6.75%
- EPS Growth
- ORIC N/A
- VINP N/A
- EPS
- ORIC N/A
- VINP 0.60
- Revenue
- ORIC N/A
- VINP $88,217,697.00
- Revenue This Year
- ORIC N/A
- VINP $17.23
- Revenue Next Year
- ORIC N/A
- VINP $51.06
- P/E Ratio
- ORIC N/A
- VINP $17.33
- Revenue Growth
- ORIC N/A
- VINP 9.03
- 52 Week Low
- ORIC $6.33
- VINP $9.01
- 52 Week High
- ORIC $16.65
- VINP $11.85
- Technical
- Relative Strength Index (RSI)
- ORIC 59.70
- VINP 56.01
- Support Level
- ORIC $9.95
- VINP $10.00
- Resistance Level
- ORIC $12.01
- VINP $10.49
- Average True Range (ATR)
- ORIC 0.86
- VINP 0.22
- MACD
- ORIC 0.04
- VINP 0.07
- Stochastic Oscillator
- ORIC 64.50
- VINP 72.73
About ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533.
About VINP Vinci Partners Investments Ltd.
Vinci Partners Investments Ltd is an alternative investment platform in Brazil. Its business segments include Private Market; Liquid Strategies; Investment Products and solutions; Financial Advisory; and Retirement Services. The company's majority of its revenue comes from the Private Market segment which is comprised of five business lines: private equity, real estate, infrastructure, credit, and special situations.